Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Partial vs Radical Nephrectomy Impact on Survival

Eur Urol Focus; ePub 2018 Feb 2; Marchioni, et al

Partial nephrectomy (PN) may help prevent renal insufficiency, hypertension, and other unfavorable health outcomes in older people with nonmetastatic T1a renal cell carcinoma (RCC), according to a study involving >4,500 individuals. Participants were ≥75 years of age with surgically-treated nonmetastatic T1a RCC. Investigators looked at the impact partial vs radical nephrectomy had on other-cause, cancer-specific, and 30-day mortality. Among the results:

  • 42% of patients had partial nephrectomy.
  • Those undergoing partial nephrectomy were 33% less likely than those who had radical nephrectomy to experience other-cause mortality.
  • The favorable outcome was seen across all ages evaluated.
  • Those in the partial nephrectomy group were 36% less likely to experience cancer-specific mortality.
  • 30-day mortality rates did not differ.


Marchioni M, Preisser F, Bandini M, et al. Comparison of partial versus radical nephrectomy effect on other-cause mortality, cancer-specific mortality, and 30-day mortality in patients older than 75 years. [Published online ahead of print February 2, 2018]. Eur Urol Focus. doi:10.1016/j.euf.2018.01.007

This Week's Must Reads

Flat pricing of ibrutinib , Sales revenues at the potential expense of patient safety

Most oncologists discuss medical marijuana with patients, Braun I et al. J Clin Oncol. 2018 May 10. doi: 10.1200/JCO.2017.76.1221.

$800M cut proposed for Centers for Medicare & Medicaid Innovation, Proposed rescission of budget authority

Medicare Beneficiary Identifiers required for billing by 2019, New Medicare cards

Trump administration unveils drug pricing initiative, American Patients First

Must Reads in Renal Cell Carcinoma

miRNAs are biomarkers for RCC prognosis, Pan X et al. Biomedicine and Pharmacotherapy 102: 2018; 718-27.

Pseudocapsule status predicts RCC prognosis, Xi W et al. The Journal of Urology 199: 2018; 915-20.

New model uses histologic subtypes to predict RCC prognosis, Leibovich B et al. European Urology 73; 2018: 772-80.

Histologic similarities in clear cell papillary RCC and tuberous sclerosis, Williamson S et al. Human Pathology 75; 2018: 10-15

IMDC risk group classification predicts sunitinib response, Rini B et al. Clinical Genitourinary Cancer; published online May 4, 2018